0000899243-17-016675.txt : 20170619 0000899243-17-016675.hdr.sgml : 20170619 20170619160552 ACCESSION NUMBER: 0000899243-17-016675 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170615 FILED AS OF DATE: 20170619 DATE AS OF CHANGE: 20170619 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dylan-Hyde Tyler CENTRAL INDEX KEY: 0001682027 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 17918577 MAIL ADDRESS: STREET 1: C/O CRISPR THERAPEUTICS AG STREET 2: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-15 0 0001674416 CRISPR Therapeutics AG CRSP 0001682027 Dylan-Hyde Tyler C/O CRISPR THERAPEUTICS AG AESCHENVORSTADT 36 4051 BASEL V8 SWITZERLAND 0 1 0 0 Chief Legal Officer Stock Option (Right to Buy) 14.43 2017-06-15 4 A 0 65000 0.00 A 2027-06-15 Common Shares 65000 65000 D This option was granted on June 15, 2017 with respect to 65,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning on July 15, 2017. /s/ Michael Esposito, attorney-in-fact 2017-06-19